FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Xarelto News

Most Popular Xarelto Story

Xarelto - 15 top blockbuster contenders

The drug: Xarelto (rivaroxaban)The disease: CardiovascularThe developers: Bayer and J&JPeak projections: Bayer estimates around $2.87 billion Xarelto has already snagged an approval for Read more...

Latest Headlines